![Michael Yang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Yang
Directeur/Bestuurslid bij
PACIRA BIOSCIENCES, INC.
Vermogen: 850 461 $ op 30-09-2026
Profiel
Michael J.
Yang is currently an Independent Director at Ionis Pharmaceuticals, Inc. and Pacira Biosciences, Inc., both since 2023, and an Operating Partner at ARTIS Ventures Management LP.
Former roles include President, Chief Executive Officer & Director at ViaCyte, Inc. (2021–2022); Director at Akcea Therapeutics, Inc. (2020); President at Johnson & Johnson; Chief Commercial Officer & Executive Vice President at ACADIA Pharmaceuticals, Inc. (2017–2021); Vice President-Sales & Marketing at Ortho Biotech, Inc.; General Manager at Veridex LLC and Therakos LLC; President at Janssen Biotech, Inc.; and President-Immunology at Janssen Pharmaceuticals, Inc. (2013–2017).
Education includes undergraduate studies at San Diego State University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-06-2026 | 19.798 ( 0,05% ) | 495 940 $ | 30-09-2026 | |
| 01-07-2026 | 7.940 ( 0% ) | 354 521 $ | 30-09-2026 |
Actieve functies van Michael Yang
| Bedrijven | Functie | Begin |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Directeur/Bestuurslid | 10-10-2023 |
| IONIS PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 14-12-2023 |
ARTIS Ventures Management LP
 ARTIS Ventures Management LP Investment ManagersFinance ARTIS Ventures seeks investment opportunities in companies located in the United states. The firm focuses on a broad range of sectors and industries. It participates in early stage capital transactions. | Private Equity Investor | - |
Eerdere bekende functies van Michael Yang
| Bedrijven | Functie | Einde |
|---|---|---|
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Algemeen Directeur | 01-10-2022 |
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 29-01-2021 |
| AKCEA THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-12-2020 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | 01-03-2017 |
| JOHNSON & JOHNSON | President | - |
Opleiding van Michael Yang
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
70
Eerstegraads connecties
13
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 13 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
Ortho Biotech, Inc. | |
Veridex LLC
 Veridex LLC Medical SpecialtiesHealth Technology Supplies vitro diagnostic oncology products | Health Technology |
Pacira Biosciences, Inc.
 Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Therakos, Inc.
 Therakos, Inc. BiotechnologyHealth Technology Develops extracorporeal photopheresis delivery system for autologous immunomodulatory therapy | Health Technology |
Janssen Biotech, Inc.
 Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
ARTIS Ventures Management LP
ARTIS Ventures Management LP Investment ManagersFinance ARTIS Ventures seeks investment opportunities in companies located in the United states. The firm focuses on a broad range of sectors and industries. It participates in early stage capital transactions. | Finance |
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cardiometabolic lipid disorders | Health Technology |
